chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Migraine, Migraine with aura
Clinical narrative: Occurred 5 weeks after vaccine and I don't think its related - But you sent me this form anyway. I experienced a possible migraine aura.  A colorful kaleidoscope for about 10 minutes.  In both eyes.  Following I had a mild migraine headache for a day and a half (usual duration of my migraines). I experienced the aura about an hour after eating very ripe pineapple. I think it was a tyramine headache and unrelated to the vaccine.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Eye swelling, Lip swelling, Throat irritation, Tongue pruritus
Clinical narrative: slight swelling of lips and eyes, scratchy tongue and throat. resolved about 1 hour with patient administered benadryl liquid dose
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypersensitivity, Swelling
Clinical narrative: slight swelling of lips and eyes, scratchy tongue and throat. resolved about 1 hour with patient administered benadryl liquid dose
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: Exposure via skin contact, Immediate post-injection reaction, Injection site extravasation, Underdose
Clinical narrative: Injected into muscle and when pulling needle out some of the liquid trickled down his arm so he did not get the full dose.  Hard to know how much he got.  Will call Pfizer this week to see if dose needs to be repeated.  His dose is only 0.2 ml so I estimate at least half of the dose was lost.
Age: 75.0
Sex: F
Vaccine: VARZOS
Symptoms: Paraesthesia, Rash erythematous, Rash macular, Swelling face
Clinical narrative: Within a few hours of administration, she reported blotchy red rash down the injection arm and that her face felt swollen & tingly.  She went to see her PCP by Friday 5/20/2022.  He prescribed a short 5 day oral steroid course.
Age: 40.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Administered 0.2 mls of Adult Pfizer vaccine to 11.5 year old male.  Mother notified 4 hours after vaccine given. Patient is doing fine with no side effects at this time which is 4 and half hours after incident. This was his third dose.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Nasal congestion, Rhinorrhoea
Clinical narrative: chonic cough, nose running at times then it's stuffy nose.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased
Clinical narrative: When asking the patient about her previous doses, she mentioned that she had no side effects with the 3rd dose. However, her blood pressure was elevated, she went to clinic and saw Dr., and her blood pressure medication was changed. The blood pressure normalized within a few days. She is unsure if the increase in BP was vaccine related.
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Discomfort, Erythema, Pain in extremity, Peripheral swelling
Clinical narrative: PT CAME IN TODAY 5/21/2022 AT 4PM COMPLAINING OF PAIN AND SWELLING AND REDNESS IN HER ARM FROM HER SHINGLES VACCINE FROM 5/14/2022.  PT STATED SHE HAS BEEN TAKING ANTI INFLAMMATORY MEDS AND USING ICE PACKS BUT IS STILL UNCOMFORTABLE
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Hemiplegia, Mobility decreased, Pain, Paraesthesia, Pyrexia
Clinical narrative: Patients boyfriend called and stated that the patient was unable to get out of bed and complaining of paralysis on her right side from the waist down as well as horrible pain, pins and needles feeling all over, and low grade fever.  Advised representative for patient to call ER and report symptoms to see if they wanted her to come in since her PCP is closed.  Requested representative call us and keep us informed as to what steps they were taking and let us know how the patient is doing.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Feeling abnormal, Headache, Nasal congestion, Pain
Clinical narrative: Fever Body Pain, Headache Chest congestion, like pneumonia,  Nose congestion,
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Pulmonary congestion, Pyrexia, Rhinorrhoea
Clinical narrative: Fever Body Pain, Headache Chest congestion, like pneumonia,  Nose congestion,
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by agency for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Amnesia, Blood gases abnormal, Blood phosphorus decreased, Blood potassium decreased, Computerised tomogram head normal
Clinical narrative: Began with typical low grade fever, body aches on 5/14/2022, as had with doses 2 & 3. No recollection of 5/14-15. Out of state family contacted neighbor on Sunday 5/15 for wellness check. Neighbor said she found me incoherent, in bed with soiled sheets. EMS was contacted and transported to Medical Center for altered mental status, where I was admitted. No memory of EMS, ED or arrival to inpatient telemetry unit. Internal medicine consulted neurology, cardiology, nephrology, infectious disease over course of inpatient stay. Earliest memory of hospitalization was Tuesday 5/17 afternoon. Discharged on Thursday 5/19 with referral to neurology, nephrology, and rheumatology.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Creatinine urine, Echocardiogram, Electroencephalogram normal, Incoherent, Incontinence
Clinical narrative: Began with typical low grade fever, body aches on 5/14/2022, as had with doses 2 & 3. No recollection of 5/14-15. Out of state family contacted neighbor on Sunday 5/15 for wellness check. Neighbor said she found me incoherent, in bed with soiled sheets. EMS was contacted and transported to Medical Center for altered mental status, where I was admitted. No memory of EMS, ED or arrival to inpatient telemetry unit. Internal medicine consulted neurology, cardiology, nephrology, infectious disease over course of inpatient stay. Earliest memory of hospitalization was Tuesday 5/17 afternoon. Discharged on Thursday 5/19 with referral to neurology, nephrology, and rheumatology.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance imaging head normal, Mental status changes, Pain, Protein urine present, Pyrexia
Clinical narrative: Began with typical low grade fever, body aches on 5/14/2022, as had with doses 2 & 3. No recollection of 5/14-15. Out of state family contacted neighbor on Sunday 5/15 for wellness check. Neighbor said she found me incoherent, in bed with soiled sheets. EMS was contacted and transported to Medical Center for altered mental status, where I was admitted. No memory of EMS, ED or arrival to inpatient telemetry unit. Internal medicine consulted neurology, cardiology, nephrology, infectious disease over course of inpatient stay. Earliest memory of hospitalization was Tuesday 5/17 afternoon. Discharged on Thursday 5/19 with referral to neurology, nephrology, and rheumatology.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Ultrasound abdomen normal, Ultrasound kidney normal, Urine analysis, Urine protein/creatinine ratio
Clinical narrative: Began with typical low grade fever, body aches on 5/14/2022, as had with doses 2 & 3. No recollection of 5/14-15. Out of state family contacted neighbor on Sunday 5/15 for wellness check. Neighbor said she found me incoherent, in bed with soiled sheets. EMS was contacted and transported to Medical Center for altered mental status, where I was admitted. No memory of EMS, ED or arrival to inpatient telemetry unit. Internal medicine consulted neurology, cardiology, nephrology, infectious disease over course of inpatient stay. Earliest memory of hospitalization was Tuesday 5/17 afternoon. Discharged on Thursday 5/19 with referral to neurology, nephrology, and rheumatology.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Cognitive disorder, Memory impairment
Clinical narrative: I have had severe memory and cognitive issues. Mostly memory. It was observed by my family and manager.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose decreased, Nausea
Clinical narrative: Patient started to feel nauseated. I feel this was due to her sugar dropping but am reporting it just to be on the safe side.
Age: 31.0
Sex: F
Vaccine: UNK
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 33.0
Sex: M
Vaccine: YF
Symptoms: Cardiac tamponade, Chest pain, Drain placement, Echocardiogram abnormal, Electrocardiogram ST segment elevation
Clinical narrative: Patient presented 1 week after vaccine with enlarging pericardial effusion, underwent pericardiocentesis and drain placement.  He developed fevers, chest pain, and EKG findings consistent with pericarditis.
Age: 33.0
Sex: M
Vaccine: YF
Symptoms: Pericardial drainage, Pericardial effusion, Pericardial haemorrhage, Pericarditis, Pyrexia
Clinical narrative: Patient presented 1 week after vaccine with enlarging pericardial effusion, underwent pericardiocentesis and drain placement.  He developed fevers, chest pain, and EKG findings consistent with pericarditis.
Age: 26.0
Sex: F
Vaccine: UNK
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 66.0
Sex: F
Vaccine: UNK
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 48.0
Sex: F
Vaccine: UNK
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Cardiac disorder, Erectile dysfunction, Headache, Lymphadenopathy
Clinical narrative: Swollen glands under armpit (temporary) lasted 6 hours.  Severe headaches, fever, night sweats, muscle soreness (lasted 24-48 hours). Erectile dysfunction, still suffering from this and haven?t had any relief in the over a year I?ve been post vaccine. I did not get the booster due to the issues and feeling like my heart isn?t working properly. Severe anxiety and feeling like my heart isn?t working right.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Night sweats, Pyrexia
Clinical narrative: Swollen glands under armpit (temporary) lasted 6 hours.  Severe headaches, fever, night sweats, muscle soreness (lasted 24-48 hours). Erectile dysfunction, still suffering from this and haven?t had any relief in the over a year I?ve been post vaccine. I did not get the booster due to the issues and feeling like my heart isn?t working properly. Severe anxiety and feeling like my heart isn?t working right.
Age: 58.0
Sex: M
Vaccine: UNK
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 84.0
Sex: F
Vaccine: UNK
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 37.0
Sex: F
Vaccine: UNK
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by agency for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by agency for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 67.0
Sex: F
Vaccine: UNK
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Anal incontinence, Dizziness, Impaired work ability, Loss of consciousness, Lymph node pain
Clinical narrative: Event:  In the morning, I got up to exercise and eat breakfast.  I was feeling dizzy.  I fainted and lost control of my bladder and bowels.  I woke up laying on my back on my kitchen floor.  I was unconscious for 1 - 3 minutes.   I stood up, ate cereal with milk, cleaned the kitchen floor and then took a shower.  I called two family members to come to my home. Treatment:  I contacted my doctor's office and the advice nurse spoke with me.  I took benadryl  (2 tablets) and increased my fluid intake.  I was unable to work the day after the vaccine. Outcomes:  I needed benadryl twice a day for 3 days and ibueprofen twice a day for 3 days.  Lymph nodes under left arm pit were swollen and painful.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Syncope, Urinary incontinence
Clinical narrative: Event:  In the morning, I got up to exercise and eat breakfast.  I was feeling dizzy.  I fainted and lost control of my bladder and bowels.  I woke up laying on my back on my kitchen floor.  I was unconscious for 1 - 3 minutes.   I stood up, ate cereal with milk, cleaned the kitchen floor and then took a shower.  I called two family members to come to my home. Treatment:  I contacted my doctor's office and the advice nurse spoke with me.  I took benadryl  (2 tablets) and increased my fluid intake.  I was unable to work the day after the vaccine. Outcomes:  I needed benadryl twice a day for 3 days and ibueprofen twice a day for 3 days.  Lymph nodes under left arm pit were swollen and painful.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by agency for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: We administered 0.25 ML instead of 0.3 ML. We contacted Patient and Pfizer. Recommendation was by CDC to Repeat dose immediately or 8 weeks later. Patient is choosing to wait 8 weeks. She is okay that I know of.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID 19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by agency for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by agency for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 66.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ear infection, Eye disorder, Fungal infection, Infection, Pain in extremity
Clinical narrative: Dark spots, red rash, right arm pained from 5 to 6 weeks, dark spots legs, arms, stomach and body itch, fungus right finger, infection right ear, right eye complication..  Medication for itch, infection and spots
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Rash erythematous, Rash macular
Clinical narrative: Dark spots, red rash, right arm pained from 5 to 6 weeks, dark spots legs, arms, stomach and body itch, fungus right finger, infection right ear, right eye complication..  Medication for itch, infection and spots
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by agency for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 77.0
Sex: U
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by agency for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 63.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Polymenorrhoea
Clinical narrative: Disruption in menstrual cycle. For 3 cycles following vaccination, my menstrual cycle was shorter by 2 days for the first 2 months then 3 days for the third month.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 57.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 76.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 95.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by agency for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 79.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by agency for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport  refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 73.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by the Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by agency for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: Location: Mobile Vaccine Unit (MVU)    Incident date/ time: 5/20/22 1530pm  12 year old female accompanied by grandmother arrived at MVU site. (Patient's guardian.)   Grandmother registered the patient with the electronic registration system.   The vaccine was prepared and administered to the patient prior to verifying the patients current vaccine status.  Grandmother had the vaccine card and provided it to the team after the vaccine was given.   At this time it was realized that the patient had received a booster vaccine of Pfizer prior.  The patient had received a booster of Pfizer on 1/15/22.  Patient was held in observation for 15 minutes.  No reactions/ adverse effects noted while in observation at the MVU.  Patient ambulated home with grandmother without incident.  Phone call made to patient and family with region lead for Nurse as witness.   5-20-22  1852  great grandmother (legal guardian)  Situation was explained.  Informed 2nd booster was given in error.  No more vaccines at this time explained.   Calm and collected demeanor.  Patient without any current complaints.  Er precautions given.  Regional Lead for Nurse contact information was given.  1858 end of conversation
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by the Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by agency for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by the Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 71.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.